Flinton Capital Management’s Ascendis Pharma A/S ASND Stock Holding History

Flinton Capital Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$253K	Buy	2,624 +320	+14%	+$35.7K	0.01%	615
2019 Q2	$265K	Buy	2,304 +144	+7%	+$17.2K	0.01%	634
2019 Q1	$254K	Sell	2,160 -848	-28%	-$74.3K	0.01%	630
2018 Q4	$188K	Sell	3,008 -2,208	-42%	-$139K	0.01%	659
2018 Q3	$370K	Buy	5,216 +160	+3%	+$11K	0.01%	571
2018 Q2	$336K	Buy	5,056 +544	+12%	+$35.8K	0.01%	534
2018 Q1	$295K	Buy	+4,512	New	+$254K	0.01%	562

Other funds holding ASND

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Flinton Capital Management's ASND Position: Q3 2019 in Review

Flinton Capital Management increased its Ascendis Pharma A/S (ASND) stake by 14% in Q3 2019, buying an estimated $35.7K and bringing the position to 2,624 shares worth $253K. The position accounts for 0.01% of the portfolio, ranked #615.

Flinton Capital Management first reported a position in ASND in Q1 2018 and has held it in 7 quarters since. The position peaked at $370K in Q3 2018. 129 funds tracked by Wall St. Rank hold ASND as of Q3 2019.

Flinton Capital Management held 2,624 shares of Ascendis Pharma A/S worth $253K as of Q3 2019.
Flinton Capital Management bought 320 Ascendis Pharma A/S shares in Q3 2019, an estimated $35.7K.
Ascendis Pharma A/S made up 0.01% of Flinton Capital Management's portfolio in Q3 2019, its #615 holding.
Flinton Capital Management first reported a position in Ascendis Pharma A/S in Q1 2018 and has held it in 7 quarters since.
Flinton Capital Management's Ascendis Pharma A/S position peaked at $370K in Q3 2018.
129 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.